We are live on ! Find out more
Marshall Wace

Marshall Wace Portfolio holdings

AUM $100B
1-Year Est. Return 35.1%
This Fund
S&P 500
This Quarter Est. Return
+10%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$44.5B
AUM Growth
-$1.18B
Cap. Flow
-$4.15B
Cap. Flow %
-9.34%
Top 10 Hldgs %
9.83%
Holding
3,927
New
652
Increased
690
Reduced
847
Closed
1,056

Top Buys

Rank Stock Value
1
BIIB icon
Biogen
BIIB
+$309M
2
XOM icon
ExxonMobil
XOM
+$302M
3
AMZN icon
Amazon
AMZN
+$291M
4
C icon
Citigroup
C
+$253M
5
SHOP icon
Shopify
SHOP
+$238M

Top Sells

Rank Stock Value
1
HUM icon
Humana
HUM
+$383M
2
JNJ icon
Johnson & Johnson
JNJ
+$312M
3
JPM icon
JPMorgan Chase
JPM
+$285M
4
T icon
AT&T
T
+$191M
5
DG icon
Dollar General
DG
+$187M

Sector Composition

Rank Sector Weight
1 Healthcare 15.63%
2 Financials 15.61%
3 Technology 14.28%
4 Consumer Discretionary 13.21%
5 Industrials 5.22%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SPLV icon
2301
Invesco S&P 500 Low Volatility ETF
SPLV
$7.24B
$562K ﹤0.01%
+8,800
New +$546K
MUSA icon
2302
Murphy USA
MUSA
$11.4B
$553K ﹤0.01%
1,980
-87,399
-98% -$25.3M
AUDC icon
2303
AudioCodes
AUDC
$239M
$553K ﹤0.01%
+30,930
New +$594K
ORIAW
2304
CALL
DELISTED
Orion Biotech Opportunities Corp. Warrant
ORIAW
$553K ﹤0.01%
54,995
FXG icon
2305
First Trust Consumer Staples AlphaDEX Fund
FXG
$235M
$552K ﹤0.01%
+8,800
New +$550K
ASTH icon
2306
Astrana Health
ASTH
$1.81B
$550K ﹤0.01%
18,600
+1,229
+7% +$39.5K
DVY icon
2307
iShares Select Dividend ETF
DVY
$23.8B
$550K ﹤0.01%
4,558
-3,100
-40% -$367K
MLKN icon
2308
MillerKnoll
MLKN
$1.56B
$549K ﹤0.01%
+26,115
New +$523K
SONO icon
2309
Sonos
SONO
$2.09B
$548K ﹤0.01%
+32,431
New +$528K
ROCL
2310
DELISTED
Roth CH Acquisition V Co. Common Stock
ROCL
$545K ﹤0.01%
53,910
AEL
2311
DELISTED
American Equity Investment Life Holding Company
AEL
$543K ﹤0.01%
+11,900
New +$479K
DCPH
2312
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
$540K ﹤0.01%
32,944
-162,601
-83% -$2.64M
CCB icon
2313
Coastal Financial
CCB
$1.08B
$539K ﹤0.01%
11,341
-39,481
-78% -$1.83M
FFIC
2314
DELISTED
Flushing Financial
FFIC
$538K ﹤0.01%
27,782
+9,685
+54% +$195K
AMTX icon
2315
Aemetis
AMTX
$99.2M
$533K ﹤0.01%
134,526
-30,287
-18% -$172K
FNV icon
2316
Franco-Nevada
FNV
$41.3B
$532K ﹤0.01%
+3,900
New +$515K
WULF icon
2317
TeraWulf
WULF
$7.48B
$531K ﹤0.01%
792,389
HRT
2318
DELISTED
HireRight Holdings Corporation
HRT
$530K ﹤0.01%
44,659
+11,714
+36% +$146K
CAT icon
2319
CALL
Caterpillar
CAT
$361B
$527K ﹤0.01%
+2,200
New +$479K
MTW icon
2320
Manitowoc
MTW
$491M
$526K ﹤0.01%
57,433
-287,677
-83% -$2.62M
TR icon
2321
Tootsie Roll Industries
TR
$2.97B
$524K ﹤0.01%
13,844
-20,931
-60% -$763K
ECPG icon
2322
Encore Capital Group
ECPG
$2.01B
$523K ﹤0.01%
+10,912
New +$526K
PRCT icon
2323
Procept Biorobotics
PRCT
$1.02B
$523K ﹤0.01%
12,579
-45,001
-78% -$1.93M
AAOI icon
2324
Applied Optoelectronics
AAOI
$6.14B
$520K ﹤0.01%
275,057
-19,641
-7% -$46.7K
CD
2325
DELISTED
Chindata Group Holdings Limited American Depositary Shares
CD
$518K ﹤0.01%
65,048
-907,577
-93% -$6.36M

Similar funds

Marshall Wace's Q4 2022 Portfolio in Review

As of Q4 2022, Marshall Wace held 3,927 positions worth $44.5B, down 2.6% from $45.6B the previous quarter. Its ten largest holdings account for 9.8% of the portfolio.

Marshall Wace withdrew a net $4.15B in Q4 2022, closing 1,056 positions and reducing 847 holdings. Its most notable exit was Humana, an estimated $383M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 16% of assets, up from 15% a quarter earlier, followed by Financials and Technology.

Against the trend, Marshall Wace opened a new position in Elevance Health worth $188M.

  • Marshall Wace's largest Q4 2022 buy was Elevance Health: 366,649 shares worth $188M.
  • Marshall Wace added most to Biogen in Q4 2022, an estimated $309M increase.
  • Marshall Wace's biggest Q4 2022 reduction was Johnson & Johnson, cutting an estimated $312M.
  • Marshall Wace fully exited Humana in Q4 2022, selling an estimated $383M.
  • Marshall Wace's ten largest holdings make up 9.8% of its $44.5B portfolio in Q4 2022.
  • Marshall Wace opened 652 new positions and closed 1,056 in Q4 2022.
  • Marshall Wace's portfolio value fell 2.6% quarter-over-quarter to $44.5B.

Based on Marshall Wace's 13F filing for Q4 2022, filed 14 Feb 2023.